ClubCorp Charity Classic Raises Record-Breaking $3,053,312
Feb 15, 2017 22:13 pm UTC| Business
DALLAS, Feb. 15, 2017 -- ClubCorp– The World Leader in Private Clubs® (NYSE:MYCC) – today announced that through its Charity Classic events the company raised $3,053,312 in 2016, breaking its previous all-time...
Healthcare Realty Trust Reports Results for the Fourth Quarter
Feb 15, 2017 22:10 pm UTC| Business
NASHVILLE, Tenn., Feb. 15, 2017 -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the fourth quarter ended December31, 2016. The Company reported net income of $52.4 million or $0.45 per...
Ambac to Release Fourth Quarter 2016 Earnings on February 28, 2017
Feb 15, 2017 22:09 pm UTC| Business
Conference Call Scheduled for March 1, 2017 Changes to be Made to Non-GAAP Measures NEW YORK, Feb. 15, 2017 -- Ambac Financial Group, Inc. (Nasdaq:AMBC) ("Ambac" or the “Company”), a holding company whose...
Forterra Announces Fourth Quarter and Full-Year 2016 Earnings Schedule
Feb 15, 2017 22:00 pm UTC| Business
IRVING, Texas, Feb. 15, 2017 -- Forterra, Inc. (“Forterra”) (Nasdaq:FRTA) plans to release fourth quarter and full-year 2016 financial results after the market close on Wednesday, March 29, 2017. A conference call to...
Great Lakes Dredge & Dock Corporation Schedules Announcement of 2016 Fourth Quarter Results
Feb 15, 2017 22:00 pm UTC| Business
OAK BROOK, Ill., Feb. 15, 2017 -- Great Lakes Dredge Dock Corporation (NASDAQ:GLDD) today announced that it will release its financial results for its three and twelve months ended December 31, 2016 on Wednesday,...
Feb 15, 2017 21:54 pm UTC| Business
CHRISTIANSTED, U.S. Virgin Islands, Feb. 15, 2017 -- Altisource Residential Corporation (“Residential”) (NYSE:RESI) will report earnings results for the fourth quarter and full year of 2016 on Wednesday, March1, 2017....
Feb 15, 2017 21:54 pm UTC| Business
Key points: A single intravenous infusion of Mesoblast's allogeneic "off-the-shelf" Mesenchymal Precursor Cells (MPCs) resulted in durable responses through nine months (39 weeks) in a 48-patient placebo-controlled,...